<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty patients with severe <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> were treated intermittently with bolus intravenous injections of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> in doses of 0.5 to 1 g </plain></SENT>
<SENT sid="1" pm="."><plain>The diseases were <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> in 9 cases, systemic necrotizing <z:mp ids='MP_0001864'>angiitis</z:mp> in 5 cases, <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease in 4 cases, <z:e sem="disease" ids="C0039483" disease_type="Disease or Syndrome" abbrv="GCA">Horton's disease</z:e> in 1 case and <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e> in 1 case </plain></SENT>
<SENT sid="2" pm="."><plain>The rationale for this treatment was resistance to previous therapies in 9 patients, initial severity of the disease in 8 and the need for prompt reduction of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> dosage owing to side-effects in 3 other patients </plain></SENT>
<SENT sid="3" pm="."><plain>No <z:hpo ids='HP_0011420'>death</z:hpo> or <z:e sem="disease" ids="C0085692" disease_type="Disease or Syndrome" abbrv="">haemorrhagic cystitis</z:e> was observed over a cumulative 120 month-patients period </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001794'>Bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> occurred in 6 cases, including <z:hpo ids='HP_0002090'>pneumonia</z:hpo> (3), and 1 case each of <z:e sem="disease" ids="C0152965" disease_type="Disease or Syndrome" abbrv="">staphylococcal septicaemia</z:e>, purulent <z:hpo ids='HP_0001287'>meningitis</z:hpo> and <z:hpo ids='HP_0000010'>urinary infection</z:hpo>: none of these <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> were life-threatening, and <z:hpo ids='HP_0000001'>all</z:hpo> were cured without sequelae </plain></SENT>
<SENT sid="5" pm="."><plain>The drug was well tolerated biologically, except for a moderate fall in neutrophils, lymphocytes and platelets </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> was stabilized or improved in 16 patients </plain></SENT>
<SENT sid="7" pm="."><plain>It remained active and required <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> at the same dosage level in 4 cases </plain></SENT>
<SENT sid="8" pm="."><plain>It is concluded that bolus injections of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> are well tolerated in short-term treatments but that their effectiveness must be confirmed by controlled studies </plain></SENT>
</text></document>